Company intelligence / Profile preview

Porton Down

Salisbury, Wiltshire, United Kingdom

Ownership: Private
Employees: ~380
Development stage: Other

Overview

Porton Biopharma is a specialized biopharmaceutical company based at the Porton Down science park in Wiltshire, England. Established in 2015 as a standalone company owned by the UK Department of Health and Social Care, it carries forward decades of research and manufacturing expertise previously held by Public Health England. The company is best known for producing Erwinase, a critical enzyme therapy for acute lymphoblastic leukemia, and the UK's strategic supply of anthrax vaccine. Porton Biopharma also offers contract development and manufacturing (CDMO) services, leveraging its high-containment facilities and expertise in complex biologics.

Therapeutic areas: OncologyInfectious Diseases
Modalities: Recombinant proteinVaccine
Industry: Biotech

Partnerships

Jazz Pharmaceuticals

Beyond the preview

Go deeper on Porton Down.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Porton Down.

Explore the full profile